Identification of Factors Associated with Failure of Arteriovenous Fistulas to Mature in Hemodialysis Patients (U01)

The summary for the Identification of Factors Associated with Failure of Arteriovenous Fistulas to Mature in Hemodialysis Patients (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Identification of Factors Associated with Failure of Arteriovenous Fistulas to Mature in Hemodialysis Patients (U01): -This initiative will support a consortium of investigators to conduct a prospective multi-center observational cohort study investigating clinical factors which may be predictive and/or are associated with the failure of newly placed arteriovenous fistulas (AVF) to mature in patients with end-stage renal disease (ESRD). -In FY 2008, the NIDDK anticipates awarding a total of $3.0 million to establish this new research program. -Six to eight awards to Participating Clinical Centers and one award to a Data Coordinating Center are anticipated.

Federal Grant Title:	Identification of Factors Associated with Failure of Arteriovenous Fistulas to Mature in Hemodialysis Patients (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-07-007
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.849
CFDA Descriptions:	Kidney Diseases, Urology and Hematology Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Dec 14, 2007
Posted Date:	Oct 10, 2007
Creation Date:	Oct 10, 2007
Archive Date:	Jan 13, 2008
Total Program Funding:	$3,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: For profit organizations other than small businesses Independent school districts Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments Public housing authorities/Indian housing authorities Small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments City or township governments State governments
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Investigations on Primary Immunodeficiency Diseases (R01); • Grants for Basic Research in Glomerular Diseases (R01); • Advances in Polycystic Kidney Disease (R01); • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...; • Calcium Oxalate Stone Diseases (R01); • Research Grants for Clinical Studies of Kidney Diseases; • Chronic Prostatitis Collaborative Research Network (Cpcrn); • Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...